Zydus Lifesciences Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. The firm's products portfolio includes active pharmaceutical ingredients, human formulations, and animal health & veterinary. It operates through the following segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Consumer Products segment represents the business of development, production, marketing, and distribution of differentiated health and wellness products. The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
33,497
Frequently Asked Questions
What is Market Cap of Zydus Lifesciences Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Zydus Lifesciences Ltd. market cap is 1.08T.
What is the 52-week high for Zydus Lifesciences Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Zydus Lifesciences Ltd. 52 week high is 1,093.65 as of May 26, 2026.
What is the 52-week low for Zydus Lifesciences Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Zydus Lifesciences Ltd. 52 week low is 835.50 as of May 26, 2026.
What is Zydus Lifesciences Ltd. stock price today?
Zydus Lifesciences Ltd. stock price today is 1,077.00.
What was Zydus Lifesciences Ltd. stock price yesterday?
Zydus Lifesciences Ltd. stock price yesterday was 1,071.00.
What is the PE ratio of Zydus Lifesciences Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Zydus Lifesciences Ltd.'s P/E ratio is 21.54.
What is the Price-to-Book ratio of Zydus Lifesciences Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Zydus Lifesciences Ltd. P/B ratio is 4.0049.
What is the 50-day moving average of Zydus Lifesciences Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Zydus Lifesciences Ltd. 50-day moving average is 930.14.
How many employees does Zydus Lifesciences Ltd. have?